Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | MEF2D |
| Upstream (Parents) |
|---|
| (<<) ADAM17 → MEF2D |
| (<<) CFL1 → MEF2D |
| (<<) FZD1 → MEF2D |
| (<<) FZD7 → MEF2D |
| (<<) IRAK1 → MEF2D |
| (<<) ITGB5 → MEF2D |
| (<<) KRTAP4-1 → MEF2D |
| (<<) MAN2A2 → MEF2D |
| (<<) RPL22L1 → MEF2D |
| (<<) RPS12 → MEF2D |
| (<<) RRP1 → MEF2D |
| (<<) STAM2 → MEF2D |
| Downstream (Children) |
|---|
| MEF2D → ATP2C2 (>>) |
| MEF2D → BBS1 (>>) |
| MEF2D → CREB3L4 (>>) |
| MEF2D → DAZAP2 (>>) |
| MEF2D → DUSP4 (>>) |
| MEF2D → KLF11 (>>) |
| MEF2D → MIA3 (>>) |
| MEF2D → MTRR (>>) |
| MEF2D → NOL9 (>>) |
